Relevant factors for the optimal duration of extended endocrine therapy in early breast cancer
Crossref DOI link: https://doi.org/10.1007/s10549-017-4601-1
Published Online: 2017-12-12
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Blok, Erik J.
,
Kroep, Judith R.
Meershoek-Klein Kranenbarg, Elma
Duijm-de Carpentier, Marjolijn
Putter, Hein
Liefers, Gerrit-Jan
Nortier, Johan W. R.
Rutgers, Emiel J. Th.
Seynaeve, Caroline M.
van de Velde, Cornelis J. H.
License valid from 2017-12-12